JEFFS ROGER 4

What Happened

• Roger Jeffs, a director of Axsome Therapeutics (AXSM), received an award of 1,721 restricted stock units (RSUs) on 2026-06-05. The award was granted at $0.00 per unit (no cash exchanged); RSUs are a derivative award that convert to common shares upon vesting.

Key Details

• Transaction date: 2026-06-05; filing date: 2026-06-09 (filed within the SEC’s two-business-day Form 4 window).
• Grant: 1,721 RSUs; reported price: $0.00; reported value: $0 (derivative award).
• Shares owned after the transaction: not specified in this filing.
• Footnotes from the filing:
  • Each RSU represents a contingent right to receive one share of common stock.
  • The RSUs vest in full on the one-year anniversary of the grant (vesting date: 2027-06-05).

Context

• RSU grants are a form of compensation, not an open-market purchase; they become actual shares only if and when they vest (and any applicable tax withholding/withholding-related share settlement occurs).
• This award does not indicate an immediate change in share ownership or a sale; it’s a deferred compensation award to be settled in shares upon vesting.